Cancer Institute A national cancer institute
designated cancer center

Ann M. Arvin

Publication Details

  • Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

    Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM. J Infect Dis. 2013; 207 (4): 574-82

    Given the high infant measles mortality rate, there is interest in whether a measles immunization regimen beginning at <12 months of age provides lasting immunity.

    PubMedID: 23300162

Stanford Medicine Resources:

Footer Links: